Voxelotor
沃塞洛托
Report date: 2024/09/26 15:10:49
NMEFirst In Class
Base Information
Drug NameVoxelotor
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2019/11/25
Country/Territory +[17]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlobal Blood Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer Europe Ma Eeig
Inactive CompaniesPfizer IncDuke UniversityGlobal Blood Therapeutics Inc +[6]
Active Indications
Inactive Indications +[10]